Inducible clindamycin resistance among clinical isolates of staphylococci

Indian Journal of Pathology and Microbiology

Volumn 52, Issue 1, 2009, Pages 49-51

  Ciraj, A ^a   Vinod, P ^a   Sreejith, G ^a   Rajani, K ^a  

^a MELAKA MANIPAL MEDICAL COLLEGE   (India)

Author keywords

Inducible clindamycin resistance; MLSBi phenotype; Staphylococcus aureus

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHENOTYPE; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 58849088465     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: 10.4103/0377-4929.44963     Document Type: Article

References (17)

1. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications. Clin Infect Dis 2002;34:482-92.
2. Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 1995;39:577-85.
3. Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppala H. Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob Agents Chemother 1999;43:2823-30.
4. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 2003;41:4740-4.
5. Weisblum B, Demohn V. Erythromycin-inducible resistance in Staphylococcus aureus: Survey of antibiotic classes involved. J Bacteriol 1969;98:447-52.
6. Watanakunakorn C. Clindamycin therapy of Staphylococcus aureus endocarditis: Clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin. Am J Med 1976;60:419-25.
7. Drinkovic D, Fuller ER, Shore KP, Holland DJ, Ellis-Pegler R. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother 2001;48:315-6.
8. Siberry GK, Tekle T, Carroll K, Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 2003;37:1257-60.
9. Kloos WE, Banerman TL. Staphylococcus and Micrococcus. In: Chapter 22, Manual of clinical Microbiology 7th ed. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Washington DC: ASM Press; 1999. p. 264-82.
10. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;45:493-6.
11. CDC Appendix (to Routine Disk Diffusion test). Clindamycin disk induction test for Staphylococcus spp. [cited 2004 Jan 15]. Available from: http://www.phppo.cdc.gov/nltn/pdf/2004/2-Hindler-D-Test.pdf.
12. Jenssen WD, Thakker-Varia S, Dubin DT, Weinstein MP. Prevalence of macrolides-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci. Antimicrob Agents Chemother 1987;31:883-8.
13. Gadepalli R, Dhawan B, Mohanty S, Kapil A, Das BK, Chaudhry R Inducible clindamycin resistance in clinical isolates of Staphylococcus aureus. Indian J Med Res 2006;123:571-3.
14. Navaneeth BV. A preliminary in vitro study on inducible and constitutive clindamycin resistance in Staphylococcus aureus from a South Indian tertiary care hospital. Int J Infect Dis 2006;10:184-5.
15. Angel MR, Balaji V, Prakash J, Brahmadathan KN, Mathews MS. Prevalence of inducible clindamycin resistance in gram positive organisms in a tertiary care centre. Indian J Med Microbiol 2008;26:262-4.
16. Delialioglu N, Aslan G, Ozturk C, Baki V, Sen S, Emekdas G. Inducible clindamycin resistance in staphylococci isolated from clinical samples. Jpn J Infect Dis 2005;58:104-6.
17. Schmitz FJ, Sadurski R, Kray A, Boos M, Geisel R, Köhrer K, et al. Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J Antimicrob Chemother 2000;45:891-4.